Filing Details
- Accession Number:
- 0001179110-19-013112
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-23 12:06:41
- Reporting Period:
- 2019-12-20
- Accepted Time:
- 2019-12-23 12:06:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1428336 | Healthequity Inc. | HQY | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1179972 | G Darcy Mott | C/O Healthequity, Inc. 15 W. Scenic Pointe Dr., Ste. 100 Draper UT 84020 | Executive Vp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-12-20 | 4,000 | $76.53 | 34,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $41.28 | 2027-03-27 | 19,897 | 19,897 | Direct | |
Common Stock | Stock Option (right to buy) | $25.39 | 2025-03-26 | 25,000 | 25,000 | Direct | |
Common Stock | Stock Option (right to buy) | $14.00 | 2024-07-30 | 100,000 | 100,000 | Direct | |
Common Stock | Stock Option (right to buy) | $61.72 | 2028-03-27 | 14,228 | 14,228 | Direct | |
Common Stock | Stock Option (right to buy) | $73.61 | 2029-03-26 | 15,337 | 15,337 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2027-03-27 | 19,897 | 19,897 | Direct |
2025-03-26 | 25,000 | 25,000 | Direct |
2024-07-30 | 100,000 | 100,000 | Direct |
2028-03-27 | 14,228 | 14,228 | Direct |
2029-03-26 | 15,337 | 15,337 | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018.
- The option is exercisable as to 9,948 shares. The option vests as to 4,974 shares on March 27, 2020 and one installment of 4,975 shares on March 27, 2021.
- The option is immediately exercisable.
- The option is exercisable as to 3,557 shares. The remaining options vest in three equal installments of 3,557 shares on March 27, 2020, 2021, and 2022.
- The option vests as to 3,835 shares on March 27, 2020. The remaining options vest as to 3,834 shares on each of March 27, 2021, 2022 and 2023.